Co-Morbidity in COPD: The Effects of Cardiovascular Drug Therapies

Publisher： Karger

E-ISSN： 1423-0356|80|1|3-7

ISSN： 0025-7931

Source： Respiration, Vol.80, Iss.1, 2010-06, pp. : 3-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Co-morbidity and acute decompensations of COPD requiring non-invasive positive-pressure ventilation

By Scala Raffaele   Bartolucci Sandra   Naldi Mario   Rossi Marcello   Elliott Mark  

Intensive Care Medicine, Vol. 30, Iss. 9, 2004-09 ,pp. : 1747-1754

Springer Publishing Company

Access to resources Recommend Favorite

Profiling leucocyte subsets in tuberculosis–diabetes co‐morbidity

By  

IMMUNOLOGY, Vol. 19-2805, Iss. 2, 2015-10 ,pp. : 243-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Profiling leucocyte subsets in tuberculosis–diabetes co‐morbidity

By  

IMMUNOLOGY, Vol. 146, Iss. 2, 2015-10 ,pp. : 243-250

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Pharmacogenetics of Lithium Response Depends upon Clinical Co-Morbidity

By Bremer Troy   Diamond Cornelius   McKinney Rebecca   Shehktman Tatyana   Barrett Thomas B.   Herold Chris   Kelsoe John R.  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 3, 2007-01 ,pp. : 161-170

Adis International

Access to resources Recommend Favorite

Co-Morbidity of Infectious and Addictive Diseases in St. Petersburg and the Leningrad Region, Russia

By  

European Addiction Research, Vol. 12, Iss. 1, 2005-12 ,pp. : 12-19

Karger

Access to resources Recommend Favorite